Yanxin Wu

Yanxin Wu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
WMWai-Kit Ming
Wai-Kit Ming
WDWenjing Ding
Wenjing Ding
Casper J.P. ZhangCasper J.P. Zhang
Casper J.P. Zhang
LZLieqiang Zhong
Lieqiang Zhong
YLYuhang Long
Yuhang Long
ZWZilian Wang
Zilian Wang
Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and it has both short- and long-term adverse effects on the health of mothers and fetuses. To investigate the effect of exercise during pregnancy on the occurrence of GDM among normal-weight pregnant women. We searched for studies published between January 1994 and June 2017 that appeared in the Web of Science, Scopus, ClinicalTrials.gov or Cochrane library databases. Randomized controlled trials that investigated the preventive effect of exercise on GDM in normal-weight women were included. Interventions including any confounding factors (e.g., dietary) were excluded. We extracted maternal characteristics, the diagnostic criteria of GDM, and basic information for intervention and obstetric outcomes. The primary outcome was the occurrence of GDM, and the secondary outcomes included gestational weight gain, gestational age at birth, birth weight, and the odds of cesarean section. A meta-analysis was conducted based on calculations of pooled estimates using the random-effects model. Eight studies were included in this systematic review and meta-analysis. Exercise during pregnancy was shown to decrease the occurrence of GDM [RR = 0.58, 95% CI (0.37, 0.90), P = 0.01 and RR = 0.60, 95% CI (0.36, 0.98), P = 0.04 based on different diagnosis criteria, respectively] in normal-weight women. Regarding secondary outcomes, exercise during pregnancy can decrease gestational weight gain [MD = − 1.61, 95% CI (− 1.99, − 1.22), P<0.01], and had no significant effects on gestational age at birth [MD = − 0.55, 95% CI (− 1.57, 0.47), P = 0.29], birth weight [MD = − 18.70, 95% CI (− 52.49, 15.08), P = 0.28], and the odds of caesarean section [RR = 0.88, 95% CI (0.72, 1.08), P = 0.21], respectively. Exercise during pregnancy can ostensibly decrease the occurrence of GDM without reducing gestational age at delivery and increasing the odds of cesarean section in normal-weight women.

20 May 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
YHYang Han
Yang Han
LKLingyi Kong
Lingyi Kong
TWTao Wang
Tao Wang
NCNiankun Chen
Niankun Chen
DWDongyu Wang
Dongyu Wang
YWYanxin Wu
Yanxin Wu
Objective: Gestational diabetes mellitus (GDM) is associated with gut microbiota dysbiosis and placental dysfunction. This study aimed to investigate whether gut microbiota-derived short-chain fatty acids (SCFAs) ameliorate placental injury and insulin resistance in GDM by suppressing ferroptosis, a novel form of iron-dependent cell death. Methods: A GDM rat model was induced by streptozotocin, and gut microbiota was depleted via a broad-spectrum antibiotic cocktail. Physiological parameters, gut microbiota composition, and SCFA levels were assessed. Placental and metabolic tissues were analyzed for ferroptosis markers (Fe 2+ , MDA, ROS), key regulatory enzymes (GPX4, ACSL4, LPCAT3), polyunsaturated fatty acid (PUFA) profiles, and inflammation. An in vitro insulin resistance model in human trophoblast cells (HTR-8/SVneo) was used to validate the causal role of SCFAs. Results: GDM and antibiotic-induced dysbiosis led to a significant depletion of SCFA-producing bacteria and reduced colonic SCFA levels. This was concomitant with severe placental ferroptosis, characterized by iron accumulation, lipid peroxidation, and downregulation of GPX4 alongside upregulation of ACSL4 and LPCAT3. PUFA substrates were significantly consumed, and systemic inflammation was elevated. In vitro , insulin resistance induced trophoblast ferroptosis and dysfunction, which was effectively rescued by SCFA treatment. SCFAs restored GPX4 expression, suppressed ACSL4/LPCAT3, preserved PUFAs, and attenuated inflammation. Conclusion: Gut microbiota-derived SCFAs play a critical protective role in GDM by inhibiting the ACSL4/LPCAT3-mediated ferroptotic pathway in placental trophoblasts, thereby improving insulin sensitivity and mitigating cellular injury. Our findings highlight the gut-placenta axis as a potential therapeutic target for GDM, warranting further validation in human studies.